Profil
Le Dr Gisela M. Schwab, MD, est directrice indépendante de Genocea Biosciences, Inc. et Chief Medical Officer & President-Medical Affairs d'Exelixis, Inc. et membre de l'American Association for Cancer Research, de l'American Society of Clinical Oncology, de l'American Society of Hematology et de l'American Society of Nephrology. Elle est membre du conseil d'administration de Genocea Biosciences, Inc. et de Cellerant Therapeutics, Inc. Le Dr Schwab a été précédemment employée en tant que directrice indépendante par Nordic Nanovector ASA, directrice indépendante par Topotarget A/S, directrice médicale et vice-présidente principale par Abgenix, Inc. et directrice de la recherche clinique et de l'hématologie par Amgen, Inc. Elle a obtenu son doctorat à la Ruprecht-Karls-Universitt Heidelberg.
Anciens postes connus de Gisela Schwab
| Sociétés | Poste | Fin |
|---|---|---|
| EXELIXIS, INC. | Directeur Technique/Scientifique/R&D | 05/09/2021 |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services | Corporate Officer/Principal | 05/09/2021 |
American Society of Hematology
American Society of Hematology Miscellaneous Commercial ServicesCommercial Services Operates as a hematology membership organisation | Corporate Officer/Principal | 05/09/2021 |
American Association for Cancer Research
American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services Engages in research, education, communication and collaboration to prevent and cure cancer | Corporate Officer/Principal | 05/09/2021 |
American Society of Nephrology
American Society of Nephrology Medical/Nursing ServicesHealth Services Engages in prevent, treat and cure kidney diseases | Corporate Officer/Principal | 05/09/2021 |
Formation de Gisela Schwab
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Abgenix, Inc.
Abgenix, Inc. BiotechnologyHealth Technology Develops therapeutic products | Health Technology |
Exelixis, Inc.
Exelixis, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cancer drug discovery company | Health Technology |
Cellerant Therapeutics, Inc.
Cellerant Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops stem cell-based cellular and antibody therapeutics for blood disorders and cancer | Health Technology |
Genocea Biosciences, Inc.
Genocea Biosciences, Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company that discovers and develops novel cancer immunotherapies | Health Technology |
Topotarget A/S
Topotarget A/S Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceuticals | Health Technology |
Ruprecht-Karls-Universität Heidelberg
Ruprecht-Karls-Universität Heidelberg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services | Health Services |
American Association for Cancer Research
American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services Engages in research, education, communication and collaboration to prevent and cure cancer | Commercial Services |
American Society of Hematology
American Society of Hematology Miscellaneous Commercial ServicesCommercial Services Operates as a hematology membership organisation | Commercial Services |
American Society of Nephrology
American Society of Nephrology Medical/Nursing ServicesHealth Services Engages in prevent, treat and cure kidney diseases | Health Services |
Nordic Nanovector ASA
Nordic Nanovector ASA Pharmaceuticals: MajorHealth Technology Develops innovative anticancer therapeutics | Health Technology |
















